Hye-Jin et al. demonstrated the anti-arthritis activity of metformin via downregulation of IL-17-producing T cells (Th17) and upregulation of regulatory T cells (Treg) in a collagen-induced arthritis (CIA) mouse model [49]. Here, IL17A is linked to arthritic joint disease.